Feb 26, 20252024/Q4-- / 7.398B--
Nov 7, 20242024/Q3-- / 7.734B--
Aug 28, 20242024/Q2-- / 7.227B--
--2024/Q1-- / 7.439B--
Feb 1, 20242023/Q44.603B / 4.598B--
US Stock MarketDetailed Quotes
NVZMY NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10
- 58.600
- +0.120+0.21%
15min DelayClose Nov 27 16:00 ET
- 58.830
- +0.230+0.39%
Post 16:09 ET
27.21BMarket Cap59.55P/E (TTM)
58.850High58.480Low9.18KVolume58.650Open58.480Pre Close539.13KTurnover0.00%Turnover Ratio37.95P/E (Static)464.36MShares72.50052wk High2.37P/B27.21BFloat Cap49.51452wk Low0.89Dividend TTM464.36MShs Float77.694Historical High1.52%Div YieldTTM0.63%Amplitude37.822Historical Low58.716Avg Price1Lot Size
NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Key Stats
NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Q3 2024 Estimates Date
Currency：EURNov 7, 2024
| Estimate | YoY | |
| Revenue | 1.04B | +73.58% |
Analyst Rating
No Data
NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: DKK
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data